Bath Cancer Research Unit
Royal United Hospital
Bath Cancer Research provides consultant haematologists/ oncologists an international service for the diseases above. Cells from their patients are tested for ex vivo drug response to a panel of cytotoxic drugs (up to 25 drugs). A report is sent to the physician to aid choice of optimum therapy. This information helps maximise the likelihood of response (and therefore survival) and reduces the risk of causing patient toxicity with no clinical benefit. Some assays are chargeable.